Ep. 82 "The New Normal for Treating Moderate-to-Severe Plaque Psoriasis" A Sun Pharma sponsored podcast
Jul 16, 2020•32 min•Ep. 82
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Hear George Han, M.D. of the Icahn School of Medicine at Mt. Sinai, and Mark Kaufmann, M.D., President-Elect at the American Academy of Dermatology, discuss the new normal for dermatologists and learn about ILUMYA™ (tildrakizumab-asmn), a treatment for moderate-to-severe plaque psoriasis. This podcast episode is sponsored by Sun Pharma. For Important Safety Information: https://bit.ly/2We7fIS. For Full Prescribing Information: https://bit.ly/2xLEfil.
For the best experience, listen in Metacast app for iOS or Android